#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

March 24, 2020 — Qure.ai, a leading healthcare AI startup, announced it has developed additional capabilities for their existing chest X-ray automation and interpretation solution that could help reduce COVID-19 induced burden on healthcare infrastructure.  

Previously, the solution could automatically generate chest X-ray interpretation reports, detect tuberculosis, chronic obstructive pulmonary diseases, lung malignancies and medical emergencies like lung collapses and cardiac disorders. Now it can additionally interpret an X-ray to detect findings indicative of COVID-19 as well as quantify the proportion of lungs affected due to the lesions. This can be used by healthcare workers for screening COVID-19 patients who need to undergo further testing as well as to monitor the progression of patients. 

Qure.ai has also developed an app-based solution, qSCOUT, for frontline health care providers. It can be used for contact tracing and remote triaging of COVID-19 patients. qSCOUT offers smartphone-based registration of patients and their contacts to remote-monitor using an integrated telehealth service. qScout also hosts an embedded AI to map hotspots for door-to-door contact tracing thereby optimizing supply chain and test kit distribution for government authorities and health workers. 

In the words of Prashant Warier, CEO and Co-founder of Qure.ai, “For the last 3 weeks, we have been working on developing technology to fight the COVID-19 pandemic. Our experience with tackling TB in more than 10 countries has helped. We are launching two offerings for combating COVID-19. At Qure.ai, we are committed to doing everything we can to fight this pandemic. We are here to help the brave and selfless healthcare workers at the frontline who are working round the clock to end this pandemic.” 

For more information: www.qure.ai

Related Coronavirus Content:

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Computed Tomography (CT)

April 2, 2026 — Nano-X Imaging Ltd. recently announced its U.S.-based subsidiary, Nanox Impact Inc., has signed a new ...

Time April 08, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Computed Tomography (CT)

March 30, 2026 — HCA Healthcare’s Good Samaritan Hospital is the first hospital in the Bay Area to implement Lumina 3D ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Cybersecurity

March 23, 2026 —Sacumen has launched ConnectX, a unified AI platform that gives cybersecurity product companies full ...

Time March 25, 2026
arrow
News | Pediatric Imaging

March 17, 2026 – OXOS Medical recently announced that its MC2 portable X-ray system is now cleared for pediatric imaging ...

Time March 23, 2026
arrow
Subscribe Now